Wei Ding - Golden Meditech CEO of GM Medicare (China) Co., Ltd
CEO
Mr. Ding Wei Zhong is Chief Executive Officer of GM Medicare Co., Ltd., subsidiary of Golden Meditech Holdings Ltd. Having specialized in the medical and medical insurance management industry since 1998. He joined the Group in April 2010. Prior to relocating to the United States, Mr. Ding has held senior positions at the Aviation Industry Office of the Shanghai Municipal Government and China Airlines Group, in addition to serving as the CEO of the United Nations Institute for Training and Research CIFAL Network since 2011.
| Age | 64 |
| Tenure | 13 years |
| Phone | 852 3605 8180 |
| Web | http://www.goldenmeditech.com |
Golden Meditech Management Efficiency
The company has return on total asset (ROA) of (2.21) % which means that it has lost $2.21 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.87) %, meaning that it generated substantial loss on money invested by shareholders. Golden Meditech's management efficiency ratios could be used to measure how well Golden Meditech manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 115.29 M in total debt with debt to equity ratio (D/E) of 0.23, which may suggest the company is not taking enough advantage from borrowing. Golden Meditech Holdings has a current ratio of 1.47, which is within standard range for the sector. Debt can assist Golden Meditech until it has trouble settling it off, either with new capital or with free cash flow. So, Golden Meditech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Golden Meditech Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Golden to invest in growth at high rates of return. When we think about Golden Meditech's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 4 records | CEO Age | ||
| Jean Neto | Ambev SA ADR | 50 | |
| Nolan Watson | Sandstorm Gold Ltd | 40 | |
| Joao Neves | Ambev SA ADR | N/A | |
| Bernardo Paiva | Ambev SA ADR | 45 | |
Management Performance
| Return On Equity | -6.87 | |||
| Return On Asset | -2.21 |
Golden Meditech Holdings Leadership Team
Elected by the shareholders, the Golden Meditech's board of directors comprises two types of representatives: Golden Meditech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Golden. The board's role is to monitor Golden Meditech's management team and ensure that shareholders' interests are well served. Golden Meditech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Golden Meditech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gang Cao, Independent Non-Executive Director | ||
| Yuen Kam, Founder, Chairman, CEO, Compliance Officer and Chairman of Executive Committee | ||
| Tsz Poon, Independent Non-Executive Director | ||
| Kwok Yu, COO and Executive Director | ||
| Qiao Gu, Independent Non-Executive Director | ||
| Wei Ding, CEO of GM Medicare (China) Co., Ltd | ||
| Jin Zhang, CEO - Hospital Management Operation | ||
| Wen Feng, Non-Executive Independent Director | ||
| Bao Shao, CEO - Chinese Herbal Medicine Operation | ||
| Daniel Foa, Independent Non-Executive Director | ||
| Yue Gao, Non-Executive Director | ||
| Xuan Duan, President - Beijing Dao Pei Hospital, MD - Shanghai Dao Pei Hospital, EVC - China Private Hospital Development League | ||
| Guang Gao, Deputy General Manager - Medical Devices Operation | ||
| Ting Zheng, Non-Executive Director | ||
| Kim Leong, CEO, Executive Director | ||
| Jian Jing, Vice President and Chief Representative, Shanghai; CEO of Golden Meditech (Shanghai) Company Limited | ||
| Kam Kong, COO, Executive Director, Company Secretary | ||
| Cheuk Lam, Secretary |
Golden Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Golden Meditech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.87 | |||
| Return On Asset | -2.21 | |||
| Profit Margin | (85.10) % | |||
| Current Valuation | 291.69 M | |||
| Shares Outstanding | 2.92 B | |||
| Shares Owned By Insiders | 72.58 % | |||
| Shares Owned By Institutions | 11.04 % | |||
| Price To Earning | 0.73 X | |||
| Price To Book | 0.48 X | |||
| Price To Sales | 7.85 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Golden Meditech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Golden Meditech's short interest history, or implied volatility extrapolated from Golden Meditech options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Golden Pink Sheet
If you are still planning to invest in Golden Meditech Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Golden Meditech's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |